Dimensional Fund Advisors LP Applied Genetic Technologies Corp Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.1 $125,860 - $223,300	-203,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.07 - $2.71 $154,001 - $390,042	-143,927 Reduced 41.49%	203,000 $217,000
Q4 2021 Feb 09, 2022	SELL	$1.87 - $2.91 $398,367 - $619,920	-213,031 Reduced 38.04%	346,927 $659,000
Q3 2021 Nov 12, 2021	SELL	$3.01 - $4.12 $308,326 - $422,028	-102,434 Reduced 15.46%	559,958 $1.69 Million
Q2 2021 Aug 12, 2021	SELL	$3.62 - $5.23 $83,799 - $121,069	-23,149 Reduced 3.38%	662,392 $2.59 Million
Q1 2021 May 14, 2021	SELL	$3.94 - $8.19 $1.02 Million - $2.11 Million	-257,840 Reduced 27.33%	685,541 $3.47 Million
Q4 2020 Feb 25, 2021	BUY	$3.99 - $5.7 $3.76 Million - $5.38 Million	943,381 New	943,381 $3.86 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.